Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line
Authors
Keywords
Apoptosis, Cell cycle, Glioblastoma, Histone deacetylase inhibitors, Phenylbutyrate
Journal
TUMOR BIOLOGY
Volume 37, Issue 1, Pages 931-942
Publisher
Springer Nature
Online
2015-08-11
DOI
10.1007/s13277-015-3781-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenylbutyric Acid: Simple Structure - Multiple Effects
- (2015) Magdalena Kusaczuk et al. CURRENT PHARMACEUTICAL DESIGN
- Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3
- (2015) Ting Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway
- (2013) A. de Conti et al. CARCINOGENESIS
- Histone deacetylase inhibitors and pancreatic cancer: Are there any promising clinical trials?
- (2013) Ioannis Koutsounas WORLD JOURNAL OF GASTROENTEROLOGY
- Gatifloxacin Induces S and G2-Phase Cell Cycle Arrest in Pancreatic Cancer Cells via p21/p27/p53
- (2012) Vikas Yadav et al. PLoS One
- Growth inhibitory effect of 4-phenyl butyric acid on human gastric cancer cells is associated with cell cycle arrest
- (2012) Long-Zhu Li WORLD JOURNAL OF GASTROENTEROLOGY
- Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
- (2011) Jean-Claude Martinou et al. DEVELOPMENTAL CELL
- PTEN Signaling pathways in glioblastoma
- (2010) Dimpy Koul CANCER BIOLOGY & THERAPY
- Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells
- (2010) Li-Yuan Bai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Housekeeping gene stability influences the quantification of osteogenic markers during stem cell differentiation to the osteogenic lineage
- (2010) Felipe Garcia Quiroz et al. CYTOTECHNOLOGY
- Nonhistone protein acetylation as cancer therapy targets
- (2010) Brahma N Singh et al. Expert Review of Anticancer Therapy
- Phenylbutyrate Induces Antimicrobial Peptide Expression
- (2009) J. Steinmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin
- (2009) KetLi Ho et al. Cancer Epidemiology
- High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray
- (2009) D. Yin et al. MOLECULAR CANCER RESEARCH
- Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer
- (2009) Noriyuki Takai et al. Journal of Oncology
- Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas
- (2008) Agda KB Lucio-Eterovic et al. BMC CANCER
- Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: Efficacy of tributyrin, a butyric acid prodrug
- (2008) Joice Kuroiwa-Trzmielina et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells
- (2007) F Condorelli et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started